Feature Channels:


Add to Favorites Subscribe Share
fbshare-AIDS and HIV

Showing results

1120 of 1284

Article ID: 710684

Southern Research taps April Brys to lead Drug Development division

Southern Research

Southern Research announced today that April M. Brys, Ph.D., an experienced life sciences executive with a strong track record in research and leadership roles, has been named vice president of the non-profit organization’s Drug Development division.

3-Apr-2019 10:00 AM EDT

Article ID: 710668

Immunotherapy Kicks and Kills HIV by Exploiting a Common Virus

Health Sciences at the University of Pittsburgh

In a first on the quest to cure HIV, University of Pittsburgh scientists report that they’ve developed an all-in-one immunotherapy approach that not only kicks HIV out of hiding in the immune system, but also kills it. The key lies in immune cells designed to recognize an entirely different virus.

3-Apr-2019 9:00 AM EDT

Article ID: 710664

HPV Infection High in Minority Men Who Have Sex with Men Despite Available Vaccine, Rutgers Study Finds

Rutgers University-New Brunswick

The rate of human papillomavirus (HPV) infection is high among young minority gay, bisexual, and other men who have sex with men despite the availability of a vaccine that can prevent the infection, a Rutgers School of Public Health study found.

3-Apr-2019 8:05 AM EDT

Article ID: 710438

University of Utah S.J. Quinney College of Law Professor Clifford Rosky among parties to file lawsuit against State of Arizona challenging anti-gay curriculum laws

University of Utah

University of Utah S.J. Quinney College of Law Professor Clifford Rosky among parties to file lawsuit against State of Arizona challenging anti-gay curriculum laws

29-Mar-2019 4:00 AM EDT

Law and Public Policy


Article ID: 710391

New method drives cellular HIV reservoirs to self-destruct

Cornell University

The human immunodeficiency virus (HIV) is no longer a death sentence, yet a cure remains elusive. While current therapies can successfully manage active infection, the virus can survive in tissue reservoirs – including macrophage cells, which play an important role in the immune system.

28-Mar-2019 1:05 PM EDT

Article ID: 710342

First Ever Living Donor HIV-To-HIV Kidney Transplant in the U.S.

Johns Hopkins Medicine

For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV. A multidisciplinary team from Johns Hopkins Medicine completed the living donor HIV-to-HIV kidney transplant on Mar. 25. The doctors say both the donor and the recipient are doing well.

28-Mar-2019 1:00 PM EDT

Article ID: 710146

Study: Privacy Concerns Keep Men from HIV Testing, Treatment

Johns Hopkins Bloomberg School of Public Health

Privacy concerns linked to both health facilities and providers are major barriers to increasing the number of men who are tested and treated for HIV in Cote d’Ivoire, suggests new Johns Hopkins Center for Communication Programs (CCP) research. CCP is based at the Johns Hopkins Bloomberg School of Public Health.

25-Mar-2019 11:10 AM EDT
  • Embargo expired:
    24-Mar-2019 11:00 AM EDT

Article ID: 709716

Exposure to HIV Virus, Treatment Before Birth Linked to Obesity Later in Life

Endocrine Society

Teens and young adults who were exposed to HIV and antiretroviral therapy before birth but are HIV-negative themselves are at increased risk of obesity and asthma-like symptoms, according to research to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.

20-Mar-2019 9:00 AM EDT
AMSSM Logo.jpg

Article ID: 710030

AMSSM Releases Updated Position Statement on Blood-borne Pathogens in the Context of Sports Participation

American Medical Society for Sports Medicine (AMSSM)

There have been significant advances in clinical and scientific research in the understanding of blood-borne pathogens (BBPs), which are pathogenic microorganisms that are present in human blood and can cause disease in humans. These pathogens include, but are not limited to, hepatitis C virus (HCV), hepatitis D virus (HDV) and human immunodeficiency virus (HIV). Updating a statement from 1995, this document is intended as a general guide to clinical practice based on the current state of evidence, while acknowledging the need for modification as new knowledge becomes available.

21-Mar-2019 12:05 PM EDT

Article ID: 710026

Naltrexone Implant Helps HIV Patients with Opioid Dependence Adhere to Medications, Prevent Relapse

Perelman School of Medicine at the University of Pennsylvania

A new study, published this month in Lancet HIV by Penn Medicine researchers, shows that a naltrexone implant placed under the skin was more effective at helping HIV-positive patients with an opioid addiction reduce relapse and have better HIV-related outcomes compared to the oral drug.

21-Mar-2019 12:00 PM EDT

Showing results

1120 of 1284

Chat now!